Research ArticleArticle
Hand Bone Loss in Patients with Psoriatic Arthritis: Posthoc Analysis of IMPACT II Data Comparing Infliximab and Placebo
Mari Hoff, Arthur Kavanaugh and Glenn Haugeberg
The Journal of Rheumatology June 2013, jrheum.121376; DOI: https://doi.org/10.3899/jrheum.121376
Mari Hoff
From the Department of Rheumatology, St. Olavs Hospital; Department of Public Health and General Practice, Norwegian University of Science and Technology; Department of Neuroscience, Division of Rheumatology, Norwegian University of Science and Technology, Trondheim, Norway; Rheumatology, Allergy, Immunology, University of California, San Diego, San Diego, California, USA; and Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway. Supported by Janssen Biotech. M. Hoff, MD, PhD, Department of Rheumatology, St. Olavs Hospital, and Department of Public Health and General Practice, Norwegian University of Science and Technology; A. Kavanaugh, MD, Dr Med, Professor, Rheumatology, Allergy, Immunology, University of California, San Diego; G. Haugeberg, MD, Dr Med, Professor, Department of Neuroscience, Division of Rheumatology, Norwegian University of Science and Technology, and Department of Rheumatology, Hospital of Southern Norway Trust. Address correspondence to Dr. M. Hoff, Department of Rheumatology, St. Olavs Hospital, Olav Kyrres gt. 17, 7006 Trondheim, Norway. E-mail: mari.hoff@ntnu.no. Accepted for publication April 9, 2013.
Arthur Kavanaugh
From the Department of Rheumatology, St. Olavs Hospital; Department of Public Health and General Practice, Norwegian University of Science and Technology; Department of Neuroscience, Division of Rheumatology, Norwegian University of Science and Technology, Trondheim, Norway; Rheumatology, Allergy, Immunology, University of California, San Diego, San Diego, California, USA; and Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway. Supported by Janssen Biotech. M. Hoff, MD, PhD, Department of Rheumatology, St. Olavs Hospital, and Department of Public Health and General Practice, Norwegian University of Science and Technology; A. Kavanaugh, MD, Dr Med, Professor, Rheumatology, Allergy, Immunology, University of California, San Diego; G. Haugeberg, MD, Dr Med, Professor, Department of Neuroscience, Division of Rheumatology, Norwegian University of Science and Technology, and Department of Rheumatology, Hospital of Southern Norway Trust. Address correspondence to Dr. M. Hoff, Department of Rheumatology, St. Olavs Hospital, Olav Kyrres gt. 17, 7006 Trondheim, Norway. E-mail: mari.hoff@ntnu.no. Accepted for publication April 9, 2013.
Glenn Haugeberg
From the Department of Rheumatology, St. Olavs Hospital; Department of Public Health and General Practice, Norwegian University of Science and Technology; Department of Neuroscience, Division of Rheumatology, Norwegian University of Science and Technology, Trondheim, Norway; Rheumatology, Allergy, Immunology, University of California, San Diego, San Diego, California, USA; and Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway. Supported by Janssen Biotech. M. Hoff, MD, PhD, Department of Rheumatology, St. Olavs Hospital, and Department of Public Health and General Practice, Norwegian University of Science and Technology; A. Kavanaugh, MD, Dr Med, Professor, Rheumatology, Allergy, Immunology, University of California, San Diego; G. Haugeberg, MD, Dr Med, Professor, Department of Neuroscience, Division of Rheumatology, Norwegian University of Science and Technology, and Department of Rheumatology, Hospital of Southern Norway Trust. Address correspondence to Dr. M. Hoff, Department of Rheumatology, St. Olavs Hospital, Olav Kyrres gt. 17, 7006 Trondheim, Norway. E-mail: mari.hoff@ntnu.no. Accepted for publication April 9, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Hand Bone Loss in Patients with Psoriatic Arthritis: Posthoc Analysis of IMPACT II Data Comparing Infliximab and Placebo
Mari Hoff, Arthur Kavanaugh, Glenn Haugeberg
The Journal of Rheumatology Jun 2013, jrheum.121376; DOI: 10.3899/jrheum.121376